Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;35:1203-1209

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brooks, W. W.
Right arrow Articles by Conrad, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brooks, W. W.
Right arrow Articles by Conrad, C. H.
Related Collections
Right arrow Other heart failure
Right arrow Hypertension - basic studies
Right arrow Hypertrophy
Right arrow Other Treatment
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2000;35:1203.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Altered Inotropic Responsiveness and Gene Expression of Hypertrophied Myocardium With Captopril

Wesley W. Brooks; Oscar H. L. Bing; Marvin O. Boluyt; Ashwani Malhotra; James P. Morgan; Naoya Satoh; Wilson S. Colucci; Chester H. Conrad

From the Cardiovascular Division, Boston Veterans Affairs Medical Center (W.W.B., O.H.L.B., N.S., W.S.C., C.H.C), Boston, Mass; the Department of Cardiology, Boston University School of Medicine, Boston, Mass; the Division of Kinesiology, University of Michigan (M.O.B.), Ann Arbor; Department of Medicine, University of Medicine and Dentistry New Jersey (A.M.), Newark, NJ; and the Department of Medicine (Cardiovascular Division), Beth Israel Hospital and Harvard Medical School (J.P.M.), Boston, Mass.

Correspondence to Wesley W. Brooks, DSc, Research Service (151), Boston VA Medical Center, 150 S Huntington Ave, Boston, MA 02130. E-mail conrad.chester{at}boston.va.gov

Abstract—Inotropic responsiveness to ß-adrenergic stimulation is generally found to be impaired in left ventricular (LV) hypertrophy and failure. To investigate the mechanisms by which angiotensin-converting enzyme inhibitor therapy may modulate inotropic responsiveness with long-term pressure overload, we studied the effects of captopril treatment on cardiac gene expression, LV muscle mechanical contraction, and intracellular calcium (Ca2+) transients from spontaneously hypertensive rats (SHR). LV papillary muscles from untreated SHR, age-matched normotensive Wistar-Kyoto rats (WKY), and SHR treated with captopril (CAPRx started at 12, 18, and 21 months of age) were studied. All animals were studied at 24 months of age or when heart failure developed. In untreated SHR, {alpha}-myosin heavy chain (MHC) gene expression and protein were decreased, the Ca2+ transient (with the bioluminescent indicator aequorin) was prolonged, and abundance of Na+/Ca2+ exchanger mRNA levels increased in comparison to WKY. Active stress development at Lmax and the maximum rate of stress development were depressed and contractile duration prolonged in SHR relative to WKY. Isoproterenol administration further decreased active stress in untreated SHR despite an increase in intracellular Ca2+ levels. In CAPRx SHR, {alpha}-MHC gene expression and protein levels were increased, the Ca2+ transient was not prolonged, Na+/Ca2+ exchanger expression was downregulated, and papillary muscle function demonstrated increased active stress and maximum rate of stress development in response to isoproterenol. The increased abundance of {alpha}-MHC mRNA in conjunction with an increase in V1 myosin isozyme suggests that captopril affects transcriptional regulation of cardiac gene expression. Restored LV inotropic responsiveness to ß-adrenergic stimulation in CAPRx SHR appears to be coupled to normalization of Na+/Ca2+ exchanger mRNA expression, upregulation of V1 myosin isozyme levels, and increased speed of contraction.


Key Words: hypertrophy, left ventricular • heart failure • calcium • receptors, adrenergic, beta




This article has been cited by other articles:


Home page
HypertensionHome page
O. H. Cingolani, X.-P. Yang, Y.-H. Liu, M. Villanueva, N.-E. Rhaleb, and O. A. Carretero
Reduction of Cardiac Fibrosis Decreases Systolic Performance Without Affecting Diastolic Function in Hypertensive Rats
Hypertension, May 1, 2004; 43(5): 1067 - 1073.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. R Sipido, P. G.A Volders, M. A Vos, and F. Verdonck
Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy?
Cardiovasc Res, March 1, 2002; 53(4): 782 - 805.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Bartel, B. Hoch, D. Vetter, and E.-G. Krause
Expression of Human Angiotensinogen-Renin in Rat: Effects on Transcription and Heart Function
Hypertension, February 1, 2002; 39(2): 219 - 223.
[Abstract] [Full Text] [PDF]